< Terug naar vorige pagina


CEO research orientation, organizational context, and innovation in the pharmaceutical industry

Tijdschriftbijdrage - Tijdschriftartikel

This study develops and tests a comprehensive framework that explains what, when, and how CEO characteristics influence firms' innovation outcomes in R&D-intensive industries. Empirical evidence from 109 CEOs from 87 U.S.-based pharmaceutical firms over the period 2001-2013 reveals that research-oriented CEOs - those with ability and motivation for science and technology - increase their firms' innovation outcomes. The results indicate that the CEO-innovation relationship strongly depends on the extent of CEOs' managerial discretion, which is shaped by the organizational context. We contribute to a more comprehensive understanding of the role of CEOs in firms ' innovation performance differentials.
Tijdschrift: R & D management
ISSN: 0033-6807
Volume: 50
Pagina's: 239 - 254
Jaar van publicatie:2020
Trefwoorden:A1 Journal article
BOF-publication weight:1
CSS-citation score:1
Authors from:Higher Education